Response to "Interventions for basal cell carcinoma: abridged Cochrane systematic reviews and GRADE assessments".
Daniel MazzoniJ MuirPublished in: The British journal of dermatology (2021)
We read with interest the Cochrane review exploring management of basal cell carcinoma (BCC).1 Despite being the most common of all malignancies, few studies met the requirements for inclusion in this analysis. Even then, the evidence from randomised control trials was mainly low to moderate. According to the Cochrane review website, "Each Cochrane Review is a systematic review that has been prepared and supervised by a Cochrane Review Group (editorial team). It attempts to identify, appraise and synthesize all the empirical evidence that meets pre-specified eligibility criteria to answer a specific research question."